Health

Expert Panel Meeting on Covid Vax Approval Begins, Health News, ET HealthWorld

New Delhi: A major meeting of a panel of experts from drug regulators is currently underway, seeking an emergency use authorization required by the Indian Serum Institute, Bharat Biotech and Pfizer for coronavirus vaccines.

Serum, which manufactures the “Covishield” vaccine developed by Oxford-AstraZeneca, and Bharat Biotech, which manufactures “Covaxin” in collaboration with ICMR, released data to the Subject Expert Committee of the Central Pharmaceutical Standards Control Organization on December 30. Did. Asked for more time to present their data.

Following Wednesday’s meeting, the panel of experts said it was analyzing additional data and information submitted by the Serum Institute of India and Bharat Biotech. The next meeting was held on January 1st.

Pfizer in the United States was the first company to apply for accelerated approval on December 4, followed by Serum and Bharat Biotech, which applied on December 6 and 7, respectively. Once the vaccines have been approved by the Subject Experts Committee, their applications will be sent to the Indian Drug Controller General (DCGI) VG Somani for approval.

While India was out of breath waiting for a silver bullet against the coronavirus, India’s drug control director hinted at vaccine approval on Thursday, saying the country “Happy New Year with something”. ..

The conference will take place the day before vaccine dry runs are scheduled to begin in all states and coalition regions, and will prepare for managing vaccine supply, storage, and logistics management, including cold chain management.

The purpose of the vaccine implementation dry run is to assess the feasibility of operation in the use of Co-WIN applications in a field environment, test the link between planning and implementation, identify challenges, and prior to actual implementation. Is to move forward.

The central government plans to vaccinate nearly 3 billion rupees in the first phase of driving. It is provided to healthcare professionals of Rs 100 million, frontline and essential workers of Rs 200 million, elderly people of Rs 2.7 billion, most of whom are over 50 years old and have comorbidities.



Expert Panel Meeting on Covid Vax Approval Begins, Health News, ET HealthWorld

Source link Expert Panel Meeting on Covid Vax Approval Begins, Health News, ET HealthWorld

Related Articles

Back to top button